RT Journal Article
SR Electronic
T1 A probabilistic approach for the study of epidemiological dynamics of infectious diseases: basic model and properties
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.16.22278844
DO 10.1101/2022.08.16.22278844
A1 Giral-Barajas, José
A1 Herrera-Nolasco, Carlos Ignacio
A1 Herrera-Valdez, Marco Arieli
A1 López, Sergio I.
YR 2022
UL http://medrxiv.org/content/early/2022/12/23/2022.08.16.22278844.abstract
AB The dynamics of epidemiological phenomena associated to infectious diseases have long been modelled with different approaches. However, recent pandemic events exposed many areas of opportunity to improve over the existing models. We develop a model based on the idea that transitions between epidemiological stages are alike sampling processes. Such processes may involve more than one subset of the population (e.g. infection), or they may be mostly dependent on time intervals defined by infectious or clinical criteria. The resulting modelling scheme is robust, easy to implement, and can readily lend itself for extensions aimed at answering questions that emerge from close examination of data trends, such as those emerging from the COVID-19 pandemic, and other infectious diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDGAPA- PAPIIT-UNAM grant IN-228820, MAHV DGAPA- PAPIIT-UNAM grant IN-102822, SILAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors